Intravascular Lithotripsy Market Size, Share, and Trends 2025 to 2034

Intravascular Lithotripsy Market (By Procedure/Application: Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD), Other Vascular Applications; By Product/Device Type: IVL Catheters, IVL Generators; By End User/Hospital Type: Cardiac and Cath Labs, Specialty Clinics, Others;) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : September 2025  |  Report Code : 6882  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Intravascular Lithotripsy Market 

5.1. COVID-19 Landscape: Intravascular Lithotripsy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Intravascular Lithotripsy Market, By Procedure/Application

8.1. Intravascular Lithotripsy Market Revenue and Volume, by Procedure/Application

8.1.1 Coronary Artery Disease (CAD)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Peripheral Artery Disease (PAD)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Other Vascular Applications (~15%)

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Intravascular Lithotripsy Market, By Product/Device Type

9.1. Intravascular Lithotripsy Market Revenue and Volume, by Product/Device Type

9.1.1. IVL Catheters

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. IVL Generators

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Intravascular Lithotripsy Market, By End User/Hospital Type

10.1. Intravascular Lithotripsy Market Revenue and Volume, by End User/Hospital Type

10.1.1. Cardiac and Cath Labs

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Intravascular Lithotripsy Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Procedure/Application

11.1.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.1.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Procedure/Application

11.1.4.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.1.4.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Procedure/Application

11.1.5.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.1.5.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Procedure/Application

11.2.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.2.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Procedure/Application

11.2.4.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.2.4.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Procedure/Application

11.2.5.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.2.5.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Procedure/Application

11.2.6.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.2.6.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Procedure/Application

11.2.7.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.2.7.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Procedure/Application

11.3.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.3.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Procedure/Application

11.3.4.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.3.4.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Procedure/Application

11.3.5.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.3.5.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Procedure/Application

11.3.6.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.3.6.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Procedure/Application

11.3.7.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.3.7.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Procedure/Application

11.4.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.4.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Procedure/Application

11.4.4.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.4.4.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Procedure/Application

11.4.5.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.4.5.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Procedure/Application

11.4.6.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.4.6.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Procedure/Application

11.4.7.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.4.7.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Procedure/Application

11.5.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.5.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Procedure/Application

11.5.4.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.5.4.3. Market Revenue and Volume Forecast, by End User/Hospital Type

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Procedure/Application

11.5.5.2. Market Revenue and Volume Forecast, by  Product/Device Type

11.5.5.3. Market Revenue and Volume Forecast, by End User/Hospital Type

Chapter 12. Company Profiles

12.1. Shockwave Medical

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Boston Scientific

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Medtronic

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Abbott

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Philips Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Terumo Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Becton Dickinson (BD)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Penumbra, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Cook Medical

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The intravascular lithotripsy market size is expected to increase from USD 0.93 billion in 2024 to USD 3.93 billion by 2034.

The intravascular lithotripsy market is expected to grow at a compound annual growth rate (CAGR) of around 15.57% from 2025 to 2034.

The major players in the intravascular lithotripsy market include Shockwave Medical, Boston Scientific, Medtronic, Abbott Laboratories, Philips Healthcare, Terumo Corporation, Becton Dickinson (BD), Penumbra, Inc., Cook Medical, Cardinal Health, Teleflex Incorporated, Asahi Intecc, Siemens Healthineers, Abiomed, OrbusNeich, Volcano Corporation, Avinger Inc., Spectranetics (Philips), Merit Medical Systems, and C.R. Bard (now BD).

The driving factors of the intravascular lithotripsy market are the rising approvals, expanding therapeutic applications, and increasing investments in advanced genetic treatment innovations.

North America region will lead the global intravascular lithotripsy market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client